sr141716 has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, ZJ; Hu, ZX; Liu, T; Wang, B; Wang, MT; Zhao, L | 1 |
1 other study(ies) available for sr141716 and Chronic Kidney Diseases
| Article | Year |
|---|---|
CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats.
Topics: Animals; Disease Models, Animal; Hypoxia; Kidney Tubules; Male; Membrane Proteins; Mitochondria; Mitochondrial Proteins; Random Allocation; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Renal Insufficiency, Chronic; Rimonabant; Sleep Apnea, Obstructive; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2021 |